XML 68 R79.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidating Financial Information (Details 4) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:                      
Net income (loss) $ 10,253 $ 11,016 $ (8,260) $ (5,872) $ (4,906) $ (13,036) $ (20,558) $ (23,748) $ 7,137 $ (62,248) $ (229,921)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Depreciation and amortization                 52,317 51,481 64,230
Interest expense related to amortization of debt issue costs and debt discount                 5,841 14,184 20,069
Stock-based compensation                 1,703 1,737 3,658
Deferred income taxes                 698 198 (34)
Net gain on disposition of property, plant and equipment                 (649) (538) (329)
Gain (loss) on sale of discontinued operations, net of income taxes                 55 (267) 0
Gain on convertible debt repayments                 (35) (2,479) 0
Asset impairments and non-cash restructuring costs                 0 13,166 86,702
Net income (loss) of unconsolidated joint ventures                 0 9,314 (3,990)
Increase in trade receivables                 (5,035) (9,792) (1,986)
Decrease in inventories                 2,221 2,954 3,233
Increase (decrease) in accounts payable and accrued liabilities                 (4,218) 27,443 9,336
Other changes in operating assets and liabilities, net                 (1,472) 1,016 (2,682)
Net cash provided by (used in) operating activities                 58,563 46,169 (51,714)
Cash flows from investing activities:                      
Payments for acquisitions                 (43,250) (996) (2,466)
Purchase of property, plant and equipment                 (29,119) (26,447) (27,381)
Proceeds from disposition of property, plant and equipment                 791 1,261 556
Proceeds from sale of discontinued operations                 4,813 2,000 0
Proceeds from sale of interests in joint ventures                 0 18,522 0
Net change in other assets                 (1,608) (748) (381)
Net cash used in investing activities                 (68,373) (6,408) (29,672)
Cash flows from financing activities:                      
Net proceeds from issuance of long-term debt                 0 0 392,942
Proceeds from issuance of common stock                 77,957 0 0
Payments on long-term debt                 (47,355) (36,334) (352,449)
Debt issue costs                 0 (1,090) 0
Employee stock purchases                 742 635 719
Net cash provided by (used in) financing activities                 31,344 (36,789) 41,212
Net increase (decrease) in cash and cash equivalents                 21,534 2,972 (40,174)
Cash and cash equivalents, beginning of year       53,782       50,810 53,782 50,810 90,984
Cash and cash equivalents, end of year 75,316       53,782       75,316 53,782 50,810
Guarantor Subsidiaries | Reportable Legal Entities
                     
Cash flows from operating activities:                      
Net income (loss)                 47,117 (13,536) (113,490)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Depreciation and amortization                 52,027 51,333 64,143
Stock-based compensation                 765 673 1,875
Deferred income taxes                 698 199 (9,953)
Net gain on disposition of property, plant and equipment                 (649) (538) (329)
Gain (loss) on sale of discontinued operations, net of income taxes                 55 (267)  
Asset impairments and non-cash restructuring costs                   13,166 86,447
Net income (loss) of unconsolidated joint ventures                   9,314 (3,990)
Increase in trade receivables                 (5,035) (9,792) (1,986)
Decrease in inventories                 2,221 2,954 3,233
Increase (decrease) in accounts payable and accrued liabilities                 (5,637) 9,646 11,228
Other changes in operating assets and liabilities, net                 1,305 (51,803) 6,890
Net cash provided by (used in) operating activities                 92,867 11,349 44,068
Cash flows from investing activities:                      
Payments for acquisitions                 (43,250) (996) (2,466)
Purchase of property, plant and equipment                 (26,940) (24,419) (27,381)
Proceeds from disposition of property, plant and equipment                 791 1,261 556
Proceeds from sale of discontinued operations                 4,813 2,000  
Proceeds from sale of interests in joint ventures                   18,522  
Net change in other assets                 (2,184) (190) (368)
Net cash used in investing activities                 (66,770) (3,822) (29,659)
Cash flows from financing activities:                      
Employee stock purchases                 539 462 545
Net cash provided by (used in) financing activities                 539 462 545
Net increase (decrease) in cash and cash equivalents                 26,636 7,989 14,954
Cash and cash equivalents, beginning of year       44,111       36,122 44,111 36,122 21,168
Cash and cash equivalents, end of year 70,747       44,111       70,747 44,111 36,122
Parent Company | Reportable Legal Entities
                     
Cash flows from operating activities:                      
Net income (loss)                 (39,980) (48,712) (116,431)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                      
Depreciation and amortization                 290 148 87
Interest expense related to amortization of debt issue costs and debt discount                 5,841 14,184 20,069
Stock-based compensation                 938 1,064 1,783
Deferred income taxes                   (1) 9,919
Gain on convertible debt repayments                 (35) (2,479)  
Asset impairments and non-cash restructuring costs                     255
Increase (decrease) in accounts payable and accrued liabilities                 1,419 17,797 (1,892)
Other changes in operating assets and liabilities, net                 (2,777) 52,819 (9,572)
Net cash provided by (used in) operating activities                 (34,304) 34,820 (95,782)
Cash flows from investing activities:                      
Purchase of property, plant and equipment                 (2,179) (2,028)  
Net change in other assets                 576 (558) (13)
Net cash used in investing activities                 (1,603) (2,586) (13)
Cash flows from financing activities:                      
Net proceeds from issuance of long-term debt                     392,942
Proceeds from issuance of common stock                 77,957    
Payments on long-term debt                 (47,355) (36,334) (352,449)
Debt issue costs                   (1,090)  
Employee stock purchases                 203 173 174
Net cash provided by (used in) financing activities                 30,805 (37,251) 40,667
Net increase (decrease) in cash and cash equivalents                 (5,102) (5,017) (55,128)
Cash and cash equivalents, beginning of year       9,671       14,688 9,671 14,688 69,816
Cash and cash equivalents, end of year $ 4,569       $ 9,671       $ 4,569 $ 9,671 $ 14,688